Open AccessLong-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
Author(s) -
Ekta Rishi,
Pukhraj Rishi,
Vishal Sharma,
Vikram Vinayak Koundanya,
Renu Athanikar
Publication year - 2016
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.184511
Subject(s) - medicine , macular degeneration , ranibizumab , photodynamic therapy , bevacizumab , ophthalmology , surgery , chemotherapy , chemistry , organic chemistry
To evaluate and compare the efficacy of combination of ranibizumab or bevacizumab with photodynamic therapy (PDT) in treating choroidal neovascularization (CNV) secondary to age-related macular degeneration (ARMD) on long-term follow-up.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom